Design Therapeutics (NASDAQ:DSGN) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at
Wall Stree
Design Therapeutics (NASDAQ:DSGN) was downgraded by analysts at
Wall Str
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at Craig Hallum to a "strong-buy" rating.
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.